Delivery Order SPE2DB20D3103-SPE2DB22FP0S6
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,348.42 contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The award has an ultimate completion date of October 28, 2024 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,316.46 firm fixed-price contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML medical supplies. The contract has an ultimate completion date of March 14, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of medical supplies, specifically INFUVITE ADULT VIAL 10ML, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,070.94 firm fixed-price delivery order contract runs through November 15, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $1,399.72 for the supply of INFUVITE PEDIATRIC VIAL 5ML pharmaceutical products. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of a pediatric intravenous medication, Infuvite Pediatric Vial 5ML, with a ceiling value of $4,808.40 and a period of performance through November 2024. As the prime contractor, Amerisourcebergen is responsible for providing...
- This is a $5,876.47 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT VIAL 10ML medical supplies, with a period of performance through July 1, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation (Corporate Office Division) for the supply of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The firm-fixed-price contract is valued at $4,647.78 and has an ultimate completion date of August 27, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,375.24, is for the delivery of INFUVITE ADULT VIAL 10ML medical products. It is a firm fixed-price contract with an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,404.20 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vials (5ml) on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,691.35 to AmerisourceBergen Drug Corp for the supply of Infuvite Adult Bulk Vial 100ML, a pharmaceutical product for federal medical procurement. This non-competitive, firm fixed price delivery order is set to be completed by December 30, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP0S6Delivery Order
This federal contract award is for the delivery of 4557690266 INFUVITE PEDIATRIC VIAL 5ML medical supplies to the Defense Logistics Agency (DLA). The $1,393.56 Firm Fixed Price contract was awarded on June 30, 2022 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 1, 2022 and was not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, both of which cover a wide range of essential pharmaceutical and medical supplies for federal government agencies and programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/30/22 |